Alex Therapeutics

Alex Therapeutics is a Sweden-based startup founded in 2018 that specializes in developing digital health solutions for the pharmaceutical industry. The company's slogan "We develop digital health solutions that enable pharmaceutical companies to better support their products and patients" encapsulates its mission to facilitate better patient outcomes through innovative technology. With a focus on user experience design, Alex Therapeutics has already served over 100,000 patients globally. The company's modular technology platform has garnered backing from major investment players, with the most recent being a €3.50M Venture Round investment on 06 April 2022. The investors behind this round include Hadean Partners, Scale Capital, Bonit Capital, and Sweet Studio, underscoring the confidence that reputable firms have in Alex Therapeutics' potential. Given its successful track record and impactful solutions, this digital health startup holds promise for continued growth and influence within the healthcare industry.